The selective NOX4 inhibitor GLX7013159 decreases blood glucose concentrations and human beta-cell apoptotic rates in diabetic NMRI nu/nu mice transplanted with human islets

Andris Elksnisa Department of Medical Cell Biology, Uppsala University, Uppsala, SwedenCorrespondence[email protected]
View further author information

Nils Welsha Department of Medical Cell Biology, Uppsala University, Uppsala, SwedenView further author information

Per Wikströmb Glucox Biotech AB, Stockholm, SwedenView further author information

Joey Laua Department of Medical Cell Biology, Uppsala University, Uppsala, SwedenView further author information

Per-Ola Carlssona Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden;c Department of Medical Sciences, Uppsala University, Uppsala, SwedenView further author information

The selective NOX4 inhibitor GLX7013159 decreases blood glucose concentrations and human beta-cell apoptotic rates in diabetic NMRI nu/nu mice transplanted with human islets

Supplemental Material

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

The selective NOX4 inhibitor GLX7013159 decreases blood glucose concentrations and human beta-cell apoptotic rates in diabetic NMRI nu/nu mice transplanted with human islets

Supplemental Material

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date